These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 10590249)

  • 21. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
    Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
    Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
    Vincent GM
    Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients.
    Smits JP; Eckardt L; Probst V; Bezzina CR; Schott JJ; Remme CA; Haverkamp W; Breithardt G; Escande D; Schulze-Bahr E; LeMarec H; Wilde AA
    J Am Coll Cardiol; 2002 Jul; 40(2):350-6. PubMed ID: 12106943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
    Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
    J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
    Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A
    Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes.
    Huang H; Zhao J; Barrane FZ; Champagne J; Chahine M
    Can J Cardiol; 2006 Mar; 22(4):309-13. PubMed ID: 16568155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De novo mutation in the SCN5A gene associated with early onset of sudden infant death.
    Wedekind H; Smits JP; Schulze-Bahr E; Arnold R; Veldkamp MW; Bajanowski T; Borggrefe M; Brinkmann B; Warnecke I; Funke H; Bhuiyan ZA; Wilde AA; Breithardt G; Haverkamp W
    Circulation; 2001 Sep; 104(10):1158-64. PubMed ID: 11535573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
    Shimizu W; Antzelevitch C; Suyama K; Kurita T; Taguchi A; Aihara N; Takaki H; Sunagawa K; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1320-9. PubMed ID: 11196553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations.
    Keller DI; Rougier JS; Kucera JP; Benammar N; Fressart V; Guicheney P; Madle A; Fromer M; Schläpfer J; Abriel H
    Cardiovasc Res; 2005 Aug; 67(3):510-9. PubMed ID: 15890323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational screening of SCN5A linked disorders in Polish patients and their family members.
    Moric-Janiszewska E; Herbert E; Cholewa K; Filipecki A; Trusz-Gluza M; Wilczok T
    J Appl Genet; 2004; 45(3):383-90. PubMed ID: 15306732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood.
    Beaufort-Krol GC; van den Berg MP; Wilde AA; van Tintelen JP; Viersma JW; Bezzina CR; Bink-Boelkens MT
    J Am Coll Cardiol; 2005 Jul; 46(2):331-7. PubMed ID: 16022964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long QT and Brugada syndrome gene mutations in New Zealand.
    Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
    Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The LQT syndromes--current status of molecular mechanisms.
    Schulze-Bahr E; Wedekind H; Haverkamp W; Borggrefe M; Assmann G; Breithardt G; Funke H
    Z Kardiol; 1999 Apr; 88(4):245-54. PubMed ID: 10408028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
    Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
    Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double SCN5A mutation underlying asymptomatic Brugada syndrome.
    Yokoi H; Makita N; Sasaki K; Takagi Y; Okumura Y; Nishino T; Makiyama T; Kitabatake A; Horie M; Watanabe I; Tsutsui H
    Heart Rhythm; 2005 Mar; 2(3):285-92. PubMed ID: 15851320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits.
    An RH; Wang XL; Kerem B; Benhorin J; Medina A; Goldmit M; Kass RS
    Circ Res; 1998 Jul; 83(2):141-6. PubMed ID: 9686753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel brugada SCN5A mutation leading to ST segment elevation in the inferior or the right precordial leads.
    Potet F; Mabo P; Le Coq G; Probst V; Schott JJ; Airaud F; Guihard G; Daubert JC; Escande D; Le Marec H
    J Cardiovasc Electrophysiol; 2003 Feb; 14(2):200-3. PubMed ID: 12693506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death.
    Antzelevitch C; Pollevick GD; Cordeiro JM; Casis O; Sanguinetti MC; Aizawa Y; Guerchicoff A; Pfeiffer R; Oliva A; Wollnik B; Gelber P; Bonaros EP; Burashnikov E; Wu Y; Sargent JD; Schickel S; Oberheiden R; Bhatia A; Hsu LF; Haïssaguerre M; Schimpf R; Borggrefe M; Wolpert C
    Circulation; 2007 Jan; 115(4):442-9. PubMed ID: 17224476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.